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Abstract: Head lice commonly evoke feelings of disgust, revulsion, anger, and
shame among parents and patients. There should, however, be no great cause
for such alarm if a physician suspects pediculosis capitis. The recent introduc-
tion of several new pediculicidal drugs now allows a choice among four distinct
therapeutic agents, which should substantially improve control of isolated
cases and epidemics. Physicians must he aware that consumer groups are
pressing public health authorities and drug manufacturers to establish proper
treatment standards and safety warnings for the use of these agents. In addi-
tion, some controversy surrounds the use of lindane in children. This paper
reviews the epidemiology and clinical appearance of pediculosis capitis in chil-
dren, with emphasis on these recent developments. Pubic lice (Phthirus pubis)
and body lice (Pedicutus humanus corporis), both of which are much less
common pediatric infestations, are mentioned only briefly.
EPIDEMIOLOGY
Pediculosis capitis is caused by a 2- to 4-mm-long
ivory-tan insect (Pediculus humanus capitis), which
has in man its only natural host. Entomologists con-
sider it a variant of the body louse, which it closely
resembles physically (1). It is an obligate human
parasite that cannot survive off its host for more
than 10 days (adults) to 3 weeks (fertile eggs) under
ideal conditions. Actual survival rates are probably
much shorter than this. An adult female lays about
six eggs per day that hatch in 8 to 10 days, with a
fertility rate of 90%. The eggs (nits) are cemented to
the shaft of hairs, usually within 1 cm of the scalp.
Fertile, unhatched nits fluoresce white with a
Wood's lamp, while a gray color signifies empty
eggs. There are usually fewer than two dozen active
adults per patient.
The insect has a transient nymphal stage with a
final metamorphosis into the characteristic cylin-
drical adult. Any of the three stages, adult, nymph,
and egg, can be infectious, but most disease is
transferred by adult organisms.
Pediculosis spreads easily through direct, per-
sonal contact or through fomites such as clothing
(caps, hooded coats, ski masks, scarfs) or toilet arti-
cles (brushes, combs, towels). Early infestations
are so mildly symptomatic that they may pass un-
noticed by patient and p^ent until detected by a
barber, beautician, or school nurse during a routine
visit.
Because of their method of transmission, head
lice are common in young school children, but prev-
alence can only be estimated since the disease is not
usually reportable. Donaldson (2) in a 1975 survey
among E t ^ s h children, estimated that 192,000
were infested — 2.4% of the school-age population
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in that country. Gratz (3) felt there were six million
cases of head lice in the United States. Slonka et ai
(4) noted a prevalence of 3% among 1783 white
pupils in a Georgia school system surveyed in 1976.
BiUstcin and Laone (5) found 76 cases per 10,000
population in a lower socioeconomic group in Sac-
ramento, California in 1979. Thus it is obvious that
the problem is not a small one. My professional
experience suggests that the number of new cases
has increased substantially in the past five years.
Females are more commonly involved than
males (6), but in some studies this difference is not
apparent (7). Hair length is often the principal factor
used to explain the higher number of females with
head lice, but Slonka et al in two separate studies of
head lice epidemics in western New York (6) and
Georgia (4) could not demonstrate a significant as-
sociation when analyzing these factors. Blacks are
rarely infested, at least in the United States (4-6)
but the reasons for this are unknown. One can
speculate that the tighter hair spirals found com-
monly in blacks offer the lice a less suitable envi-
ronment. Depending upon the epidemic, attack
rates of 8% to 15% per year are not uncommon in
the United States, and in some developing countries
may reach 50%. No age is immune, and local com-
munity practices such as prevalence of preschools
do much to modify statistics. It is my experience
that pediculosis capitis is most common in grades K
through 6, but other statistics report higher rates in
adults (8).
Prevalence of pediculosis is greatest in lower so-
cioeconomic groups (4-6), where it is presumed
that large family size, crowding, bed sharing, and
lower standards of hygiene allow for more rapid
transmission. Large epidemics, however, can be
seen in public, private, and parochial schools in all
sections of society. Sharing of school lockers and
random use of coat hooks are important vectors in
influencing the disease spread in schools.
TREATMENT
General
The general treatment of pediculosis capitis in-
volves attempts to prevent its spread among ex-
posed members of the family and others in the com-
munity. For isolated cases, it is probably enough to
treat the patient and all members of the family. Par-
ents should be strongly encouraged to contact
school authorities to prevent epidemic spread
among classmates. Once the problem becomes en-
trenched in a school, more aggressive measures are
necessary.
Communication with the parents of all school-
children is a must. The presence of the epidemic
must be explained and suggestions made for self-
treatment or referral to family physicians. The ex-
act methods suggested depend upon the preferences
of local authorities. Within the school itself, every
effort must be made to control infection. Students
and staff should know that sharing of hats, coats,
scarfs, caps, combs, and towels is an important fac-
tor in the spre^ of this disease. Teachers should be
given some common-sense education in how to
screen the heads of children, for example, a fre-
quent false positive finding is the small flakes of
dandruff that commonly cling to the sides of hairs.
These scales can easily be removed with very gentle
traction. Nits, on the other hand, being cemented to
the hair shaft, are not freely movable, but can be
avuised if traction is substantial.
In the home, all articles in contact with infected
patient's scalp must be thoroughly washed or dis-
infected. Pillows, blankets, towels, caps, hoods,
and the like can either be stored in plastic bags
for approximately a month or washed. Combs,
brushes, and other personal toilet articles are much
more difficult to sterilize. Vigorous washing in hot,
soapy water is probably adequate to remove most
adult lice from these grooming aids. For those who
fee! the need to be more meticulous, a short soak
(one hour) in rubbing ak:ohol is inexpensive, satis-
factory, and safe. I do not suggest the use of micro-
wave ovens to sterilize combs and brushes since




One percent lindane shampoo (Kwell, Scabene) is
effective treatment for cases of pediculosis capitis,
corporis, and pubis. The drug should be rubbed into
the scalp of the patient and all f^nily members,
whether symptomatic or not, and allowed to remain
for 10 minutes. Lindane cream or lotion is not nec-
essary, but if it is used, the contact time should
remain 10 minutes, not the 6 to 12 hours suggested
in many references. Only the scalp need be tressed
in cases of pediculosis capitis.
There are several reports of the development of
head lice resistant to Undane (9). These have only
occurred in Europe where this agent is used in
much lower concentrations than in the United
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States. It is not known if these lice are resistant to
the 1% lindane currently in use in the United States.
Some individuals and consumer groups feel that
lindane is not a safe pediculicide. A recent issue of
Consumer Reports (10) summarized these argu-
ments as (1) lindane is a toxic compound, (2) it is
irritating, (3) it is a potential carcinogen, and (4)
there are safer existing alternatives. For an in-depth
discussion of these problems, the reader is referred
to two recent reviews (11, 12).
The above points should be placed in the appro-
priate context. First, there is no question that lin-
dane can be toxic if misused or ingested. It is impior-
tant that patients and their parents be fully informed
that lindane should be applied once and not re-
peated within a week. If such instructions are fol-
lowed, there should be no toxic reactions. This is
based on the fact that lindane has been used for 20
years and over 20 million doses have been sold for
the treatment of head lice. During this time, Kramer
et al (13, 14) found that there were no convulsions
following the proper use of lindane for the treatment
of head lice. Almost all repwrts of toxicity have
come from ingestion or prolonged administration
for the treatment of scabies.
There is no doubt that the drug is absorbed; how-
ever, this is true for all agents applied to the skin.
Ginsburg et al studied the absorption of lindane in
young patients with head lice (15) and with scabies
(16). Patients with head lice had approximately one-
thirtieth the blood level of those with scabies (0.96
ng/ml mean peak blood level vs 28 ng/ml).
Second, mild irritation can occur with the use of
lindane and all other pedicuiicides, particularly if
excoriation and infection are present. All specific
pedicuiicides are irritating to mucous membranes
such as the eyes.
Third, in chronic high-dose animal feeding stud-
ies, lindane has been shown to be a possible ceircin-
ogen (see Rasmussen [10] for a general review). It
produced hepatomas in one species in laboratory
animals, but not in several others. These results
were obtained after long-term high-dose feeding
studies that produced substantial (20% to 25%)
animal mortality from other causes. To gain the
same exposure, a person would have to ingest a 30-
gm tube of Kwell (1% lindane) on a daily basis from
age 1 year through age 50. Several other feeding
studies at lower doses, as weU as several skin paint-
ing studies, have not shown a carcinogenic effect.
Those who believe that iindane is a ca-cinogen
should also appreciate that several other agents
used for the treatment of head lice are available in a
form that consists in part of petroleum distillates,
which, so evidence suggests, are also potentially
carcinogenic (17). Regardless of these points of
view, it is very unlikely that a single or even several
applications applied to a small area of the body such
as the scalp would cause any significant carcino-
genesis. This position is also supported by the Con-
sumers Reports article.
Finally, the safety and efficacy of the alternate
scabicides have not been studied nearly as exten-
sively as lindane. Lindeme is sold over the counter
in several major countries such as Canada. Reports
of serious toxicity from its application in treatment
of head lice are nonexistent in these areas. Given
the freedom to abuse the drug that comes with over-
the-counter use, this suggests that the potential for
toxicity following the treatment of head lice is ex-
tremely small.
Pyretkrins
Pyrethrins are extracts from the flowers of members
of the chrysanthemum family. Pyrethrins are usu-
ally used in combination with piperonyl butoxide,
an agent that in some way enhances the effec-
tiveness of the pyrethrin as an insecticide. Most of
these products, such as Rid, A-200, and others, are
contained in a vehicle that consists of petroleum
distillates such as kerosene. Consequently, these
agents can be irritating, particularly if they contact
mucous membranes. Pyrethrins have been well
studied in the treatment of pediculosis.
Smith and Walsh (18) conducted an open study
comparing the efficacy of lindane shampoo with the
over-the-counter pyrethrin-based pediculocide.
Rid. The study was conducted in a group of 30
adults with pubic lice who were randomly assigned
treatment with one of the two test agents. Both
groups were treated with a single 5- to 10-minute
application and returned in one week to ascertain
the presence of active disease. The results showed
lindane and pyrethrin products to be equally effec-
tive — all 30 patients were totally free of active dis-
ease. Newsom, Fiore, and Hackett (19) conducted a
similar study of 30 adults with pubic lice. Patients
were randomly assigned treatment with either a
0.3% pyrethrin-3.0% piperonyl butoxide lotion
(Rid) or a \% lindane lotion (Kwell). The pyrethrin
mixture was given in a single 10-minute application
and the lindane was used for a 12-hour application.
A follow-up visit a week after treatment verified
that all patients were cured. Lange et ai (20) treated
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112 patients with a shamfKKi containing pyrethrins.
All were given a single lO-minute application and
followed up at one week for the presence of live
lice. Only six patients had live lice immediately be-
fore the second treatment. Following the second
treatment, no patient had live lice. Robinson and
Shepherd (21) conducted a random study of syner-
gized pyrethrins compared to lindane in the treat-
ment of 26 children between the ages of 7 and 10
years with head lice. These authors used three con-
secutive weekly applications, and reported that
both agents were equally effective.
All of these studies indicate that pyrethrins and
lindane are effective in the treatment of head and
pubic lice but no controls exist that separate the
effectiveness of drug from vehicle. As a further ad-
vantage, many pyrethrin products are sold with a
plastic nit comb, which has recently been rede-
signed to increase efficacy. Even more effective
metal nit combs can be purchased separately as the
Medi Comb (Nitex Labs, Boston, MA), Derboc
Comb (Johnson Manufacturing, Boonton, NJ), or
Innomed Comb (Innomed Inc., Greenwich, CT).
While no known comb will remove all nits, the
closely spaced teeth do assist in removing this
bothersome sign of pediculosis capitis.
0.5% Malathion
Taplin et al (22) evaluated the efficacy of 0.5%
malathion lotion (Prioderm) in the treatment of sub-
jects with head lice. They conducted a double-
blind, controlled study of 115 subjects (mean age 9
years) who used either 0.5% malathion lotion or its
vehicle to treat active head lice. Both preparations
were allowed to remain on the hair for 12 hours.
Patients were evaluated at the end of a week, at
which time there was a cure rate of 95.4% (62/65)
for the active agent and 15% for the vehicle, a statis-
tically significant difference (P < 0.001).
This study indicates that 0.5% malathion lotion is
an effective agent for the treatment of pediculosis
capitis and it is quite probable that the same efficacy
wilt also extend to pediculosis of the body and pubic
region. A long contact time (12 hours) represents
one minor disadvantage of the use of malathion
over some of the other agents. Shorter contact
times were not studied by this group and may be
effective.
Malathion is an organic phosphate, and although
these compounds are known to inhibit the enzyme
acetylcholinesterase, their toxicity for humans ap-
pears to be quite minimal. Malathion is rapidly bro-
ken down in humans, but gross contamination has
been reported to cause symptoms of cholinergic
toxicity (not from the application of this product,
however).
10% Crotamiton
Karacic and Yawalkar (23) treated 49 patients with
pediculosis capitis using a 10% crotamiton lotion.
The study population included 26 patients under 10
years of age. The lotion was rubbed into the scalp
and left on for 24 hours, and the scalp was examined
on the seventh posttreatment day. This single appli-
cation cured pediculosis capitis in 96% of the 49
patients. In two patients, a second application was
necessary.
A minor disadvantage of crotamiton lotion in the
treatment of patients with pediculosis capitis is the
long contact time required (24 hours). While shorter
contact times may be effective, they were not
studied by these authors.
Those concerned about the safety of lindane sug-
gest crotamiton as a safe choice. Toxicity of this
drug has not been as scrutinized as that of lindane
because it is only used one-twenty-fifth as fre-
quently. Safety and absorption of crotamiton in
children, adults, and pregnant women have not
been evaluated.
Pediculosis of the Eyelashes
Pediculosis of the eyelashes is not a common prob-
lem in children, but when it occurs, the responsible
organism is the pubic rather than the head louse
(24). Prepubertal children lack the appropriate
pubic environment for crab lice, which are forced to
take up residence in the next best terrain — the
eyelashes. The diagnosis should be considered
when a child complains of Ud pruritus, scaling,
crusting, or purulent discharge. The diagnosis can
be made easily if the area is carefully examined with
a strong light and preferably with a magnifying lens.
If the clinical appearance is not obvious, a small set
of smooth tweezers can be used to epilate eggs,
organisms, or a few hairs for microscopic examina-
tion.
Lindane, pyrethrin, crotamiton, and malathion
are far too irritating to be used on such a sensitive
surface as the eyelids. There are, however, several
other acceptable alternatives (25).
The treatment of choice for lice of the eyelashes
is petrolatum (Vaseline). The ointment is rubbed on
the eyelashes with a finger or cotton swab three to
five times a day. The exact mechanism of action is
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uncertein, but the lice may either be suffocated or
slip off and foil to their death. Obviously, a diligent
search should be made for the presence of pubic lice
within the family, and all infected or exposed adults
treated appropriately from the neck down.
Physostigimine, 0.25% (Eserine) can also be ap-
plied to the eyelashes several times a day for three
days. This agent is a pupillary constrictor, and con-
sequently inhibits dark adaption. This appears to be
its only major side effect.
Also potentially useful are fluorescein eye drops.
Matthew et al (26) reported on their accidental ob-
servation that 20% fluorescein drops applied to the
lids and lashes of a patient with phthiriasis palpe-
brarum produced an immediate toxic effect on the
lice. The authors extended their observations to a
small group of patients with head lice, reporting the
most notable effects with 10% to 20% concentra-
tions. The obvious disadvantage to this form of
therapy is that it leaves an orange-green stain on the
skin. It may, however, be useful for the patient who
is unwilling or unable to use the other previously
mentioned ingredients.
Yellow oxide of mercury, 0.1%, is an outmoded
treatment and the substance is difficutt to obtain.
SYSTEMIC THERAPY
There are few situations in which one of the four
preceding topical pediculicides is not effective. A
rare patient may have severe matting of the hair and
dense infestation that will not respond to topical
agents. In this situation, only two choices remain —
shaving the scalp to remove the organisms physi-
cally or oral treatment with cotrimoxazole. Sashin-
dran and associates (27) studied 20 female patients
with pediculosis capitis. They were treated once or
twice a day with one tablet of cotrimoxazole (80 mg
trimethoprim plus 400 mg sulfamethoxazole, - Bac-
trim or Septra) twice daily for three days. Within
the next 12 to 48 hours, the bee migrated to the bed
clothes and later died. Neither trimethoprim nor
sutfamethoxazole showed any effect on the lice
when used separately. Cotrimoxazole has no effect
on nits, and consequently a second course of ther-
apy must usually be given 7 to 10 days after the first.
This regimen was used in Sashindran's patients and
produced complete cures in all.
The reader should be aware that these agents wHl
only rarely (if ever) be necessary in the treatment of
pediculosis, and that their use can be associated
with major side effects such as toxic epidermal nec-
rolysis.
PARENT SUPPORT GROUPS
The National Pediculosis Association, (Post Office
Box 149, Newton, MA 02161; telephone (617) %9-
5623) is a common-interest group for parents. They
provide a central depository of advice on control of
school epidemics, and are an effective lobby for
improved consumer labeling of over-the-counter
and prescription pediculicides.
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